KRYSTEXXA PEGLOTICASE K Trademark

Trademark Overview

On Wednesday, January 11, 2017, a trademark application was filed for KRYSTEXXA PEGLOTICASE K with the United States Patent and Trademark Office. The USPTO has given the KRYSTEXXA PEGLOTICASE K trademark a serial number of 87297485. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 27, 2020. This trademark is owned by HORIZON PHARMA RHEUMATOLOGY LLC. The KRYSTEXXA PEGLOTICASE K trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of rheumatological conditions; pharmaceutical preparations for the treatment of hyperurecemia
krystexxa pegloticase k

General Information

Serial Number87297485
Word MarkKRYSTEXXA PEGLOTICASE K
Filing DateWednesday, January 11, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 27, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PEGLOTICASE"
Goods and Servicespharmaceutical preparations for the treatment of rheumatological conditions; pharmaceutical preparations for the treatment of hyperurecemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 18, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHORIZON PHARMA RHEUMATOLOGY LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLake Forest, IL 60045
Party NameHORIZON PHARMA RHEUMATOLOGY LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLake Forest, IL 60045

Trademark Events

Event DateEvent Description
Monday, July 27, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 27, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, April 24, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 24, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 24, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 24, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 24, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2019EXTENSION 5 GRANTED
Monday, November 18, 2019EXTENSION 5 FILED
Wednesday, November 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 18, 2019TEAS EXTENSION RECEIVED
Friday, June 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2019EXTENSION 4 GRANTED
Wednesday, June 19, 2019EXTENSION 4 FILED
Wednesday, June 19, 2019TEAS EXTENSION RECEIVED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 19, 2018EXTENSION 3 GRANTED
Wednesday, December 19, 2018EXTENSION 3 FILED
Wednesday, December 19, 2018TEAS EXTENSION RECEIVED
Thursday, June 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 19, 2018EXTENSION 2 GRANTED
Tuesday, June 19, 2018EXTENSION 2 FILED
Tuesday, June 19, 2018TEAS EXTENSION RECEIVED
Thursday, December 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2017EXTENSION 1 GRANTED
Tuesday, December 12, 2017EXTENSION 1 FILED
Tuesday, December 12, 2017TEAS EXTENSION RECEIVED
Wednesday, June 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 13, 2017ASSIGNED TO EXAMINER
Wednesday, January 18, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 14, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

pegloticase krystexxa pharmaceutical treatment preparations hyperurecemia rheumatological conditions